Abstract Body

Over the past four decades, remarkable progress has been made in understanding HIV epidemiology, pathogenesis, treatment, and prevention from the combined efforts of community members, clinicians, investigators, and funding agencies worldwide. Yet more work and new approaches are needed to achieve the ambitious goal of ending the epidemic and ensuring optimal quality of life for those living with HIV.  To encourage and stimulate the next generation of investigators, the CROI Program Committee organizes an annual Workshop for New Investigators and Trainees comprised of expert and comprehensible talks to cover current knowledge and controversies in basic, clinical and public health investigation into HIV and related infections, and to highlight relevant work to be presented over the ensuing days at CROI. This year’s Workshop will begin with Dr. Wes Sundquist who will review aspects of HIV-1 replication and innate immunity, in particular recent developments in our understanding of mechanisms of virus sensing, early steps in the viral replication cycle, and virus-host arms races.  Dr. Richard Koup will cover recent preclinical HIV vaccine advances, concentrating on efforts to induce either broad neutralizing antibody responses or protective CD8 T cells, and discuss the latest data on the development and use of broadly neutralizing antibodies in prevention and treatment of HIV.  Dr. Hermione Lyall will review ongoing challenges in prevention of vertical HIV transmission during pregnancy and breastfeeding, short and long term challenges of getting infants on to treatment, and approaches to sustaining health and supporting ‘undetectable=untransmittable’ in youth with HIV.  Dr. Susan Buchbinder will describe the current status of new infections globally, and discuss recent advances in biomedical HIV-1 prevention including treatment as prevention, pre-exposure prophylaxis, topical preventive agents, HIV vaccines, and combination approaches to HIV prevention. Finally, Dr. Nicolas Chomont will review the mechanisms that contribute to HIV persistence during ART, highlight the role of cell proliferation in that process and present recent therapeutic approaches aimed at curing HIV infection.  The Workshop serves as the initial opportunity for Trainees and New Investigators to interact with Program Committee members. Such interactions will continue during new morning sessions organized to provide support and guidance for emerging investigators at this year’s CROI.